This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Browse our events, training, articles and people by topicclose

Popular sectors

A - Z

Browse Topicsappsclose
search

Peptides & Oligonucleotides

Accelerate oligonucleotide and peptide products from early discovery to late-stage development & commercialization.

Events

Showing 4 of 7 eventsView all events

Next Generation CAR & T Cell Therapies

November 2-5, 2020, in Pacific Standard Time (PST)

CAR and T Cell Therapies: Pioneering point of care with innovative manufacturing and commercialization strategies

Next Generation Protein Therapeutics & Bioconjugates Summit

November 2-5, 2020, in US Pacific Standard Time (PST)

LOOKING BEYOND ANTIBODIES TO TRANSFORM PROMISING NOVEL MOLECULES INTO NEXT GENERATION MEDICINE

TIDES Europe: Oligonucleotide and Peptide Therapeutics

11-13 November 2020, Presented in Central European Time (CET)

EUROPE’S #1 FORUM FOR OLIGONUCLEOTIDE AND PEPTIDE LEADERS TO BUILD SUCCESSFUL PARTNERSHIPS AND ACCELERATE NEW PRODUCTS TO MARKET

AsiaTIDES: Oligonucleotide & Peptide Therapeutics

February 24-26, 2021, Kyoto, Japan

THE ONLY EVENT IN ASIA BRINGING TOGETHER SCIENCE, TECHNOLOGIES AND PARTNERS TO ACCELERATE OLIGONUCLEOTIDE AND PEPTIDE MOLECULES TO MARKET

Articles & Video

Showing 9 of 50 articles & videoView all articles & video
Featured
EBook

The Future of the Oligonucleotide and Peptide Therapeutics Industry

What changes could happen in the oligonucleotide and peptide therapeutics industry over the next decade? This interactive ebook gathers predictions from industry professionals all over the globe.

Premium
Antibodies

Emerging Therapies Content Library: Whitepapers and Reports Collection

Explore our collection of exclusive whitepapers and reports covering the most exciting developments in emerging therapies with one simple registration.

CMC

Innovating CMC for Oligonucleotide and Peptide Therapeutics

In a new ebook, we look at ways to optimize chemistry manufacturing and controls for oligonucleotide and peptide therapeutics.

Tides

Post-event Report - TIDES: Oligonucleotide and Peptide Therapeutics

September 2020 saw the first TIDES event made virtual. This report provides a summary of the key topics, highlights and sessions of the week.

COVID-19

Report: Partnering And Deal-Making in Pharma through the Pandemic

Healthcare

REPORT: The Future of Healthcare Post COVID-19

Diversity

Diversity and Inclusion in Biotech

Biopharma

SURVEY: Partnering and Deal-Making in Biopharma through the Pandemic

Cell therapies

42% of pharma industry believe cell and gene therapies to be most promising therapeutics

SPONSORSHIP & EXHIBITION OPPORTUNITIES

There are many ways for your organisation to engage a qualified audience of 40,000+ TIDES executives and scientists, including 2,000+ annual attendees gathered across the globe! Share your strategy and plans so we can help you identify the best opportunities to reach your objectives. Our team will collaborate with you to develop a bespoke program tailored to your unique needs.

To find out more, contact Michael Dunnet, Head of Portfolio Sales:
michael.dunnet@informa.com | +1 (857) 504-6732

All opportunities can be customised to align with your needs and budget. Examples may include:

  • Exhibition space
  • Speaking slots and onsite video interviews
  • High-impact branding and messaging
  • Private/public hosted events (lunches, breakfasts, and receptions)
  • Custom digital campaigns
DOWNLOAD 2020 SPONSOR PROSPECTUS

Copyright © 2020 Informa Connect Limited. Registered in England & Wales with number 01835199, registered office 5 Howick Place, London, SW1P 1WG.